⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL856592 | 1.00 | — | — | |
| SCHEMBL127190 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1485343 | 1.00 | — | — | |
| SCHEMBL993593 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL10988485 | 1.00 | — | — | |
| Phosphoric Acid SCHEMBL4422997 | 0.91 | NOS3 (0.44) | — | |
| SCHEMBL9179525 | 0.87 | NOS3 (0.50) | — | |
| SCHEMBL9179523 | 0.87 | NOS3 (0.50) | — | |
| Trifluoroacetic Acid SCHEMBL2321048 | 0.87 | NOS2 (0.42) | — | |
| SCHEMBL5606478 | 0.84 | NOS3 (0.56) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1746 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240261422-A1 | ANTHRACYCLINE ANTIBODY CONJUGATES | SEAGEN INC (US) | 2024-08-08 | — | — | US | claimed |
| CN-118103059-A | Self-assembled nanoparticles based on amphiphilic peptides | 巴林萨斯生物疗法北美公司 | 2024-05-28 | — | — | CN | claimed |
| US-20240123079-A1 | IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES | SEAGEN INC. | 2024-04-18 | — | — | US | claimed |
| EP-4346906-A1 | ANTHRACYCLINE ANTIBODY CONJUGATES | Seagen Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| CN-117580593-A | Anthracycline antibody conjugates | 思进公司 | 2024-02-20 | — | — | CN | claimed |
| EP-4277904-A1 | IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES | Seagen Inc. (US) | 2023-11-22 | — | — | EP | claimed |
| CN-116829551-A | Immunomodulatory antibody drug conjugates | 思进公司 | 2023-09-29 | — | — | CN | claimed |
| WO-2022251850-A1 | ANTHRACYCLINE ANTIBODY CONJUGATES | SEAGEN INC. (US) | 2022-12-01 | — | — | WO | claimed |
| US-20220380425-A1 | ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE | CADILA HEALTHCARE LIMITED (IN) | 2022-12-01 | — | — | US | claimed |
| WO-2022155518-A1 | IMMUNOMODULATORY ANTIBODY-DRUG CONJUGATES | SEAGEN INC. (US) | 2022-07-21 | — | — | WO | claimed |
| WO-1995000535-A1 | OPTICALLY PURE CALPAIN INHIBITOR COMPOUNDS | ALKERMES, INCORPORATED (US) | 1995-01-05 | — | — | WO | claimed |
| EP-0564561-A4 | PEPTIDES KETOAMIDES, KETOACIDS, AND KETOESTERS | GEORGIA TECH RES INST (US) | 1994-08-10 | — | — | EP | claimed |
| US-5306824-A | Enzyme inhibitors; purifying proteins | GEORGIA TECH RESEARCH CORPORATION (US) | 1994-04-26 | — | — | US | claimed |
| EP-0564561-A1 | PEPTIDES KETOAMIDES, KETOACIDS, AND KETOESTERS | GEORGIA TECH RESEARCH CORPORATION (US) | 1993-10-13 | — | — | EP | claimed |
| WO-1992012140-A1 | PEPTIDES KETOAMIDES, KETOACIDS, AND KETOESTERS | GEORGIA TECH RESEARCH CORPORATION (US) | 1992-07-23 | — | — | WO | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| EP-0175180-A1 | Histargin-related compounds, a process for their preparation and their use as medicaments | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1986-03-26 | — | — | EP | claimed |
| EP-0105193-A2 | Spergualin-related compounds, processes for the preparation thereof and their use as medicaments | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1984-04-11 | — | — | EP | claimed |